Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1861-0714
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels ; day:5 ; month:3 ; year:2019 ; pages:1-6
Clinical research in cardiology supplements ; (5.3.2019), 1-6
- Creator
-
Schettler, V. J. J.
Neumann, C. L.
Peter, C.
Zimmermann, T.
Julius, U.
Hohenstein, B.
Roeseler, E.
Heigl, F.
Grützmacher, P.
Blume, H.
Klingel, R.
Vogt, A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11789-019-00094-4
- URN
-
urn:nbn:de:101:1-2019033104592411998246
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schettler, V. J. J.
- Neumann, C. L.
- Peter, C.
- Zimmermann, T.
- Julius, U.
- Hohenstein, B.
- Roeseler, E.
- Heigl, F.
- Grützmacher, P.
- Blume, H.
- Klingel, R.
- Vogt, A.
- SpringerLink (Online service)
Other Objects (12)
Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels
Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification
Current Role of Lipoprotein Apheresis
Der Biomarker Lipoprotein(a) – Lp(a) in der Diagnostik der peripheren arteriellen Verschlusskrankheit
Der Biomarker Lipoprotein(a) – Lp(a) in der Diagnostik der peripheren arteriellen Verschlusskrankheit
[Abstract der Posterpräsentation] Bestimmung von Lipoprotein Lp(a): Vergleich zweier Enzymimmunoassays und eines Radioimmunoassays
LPA, Abt. LP 4 (Flak).- Personalangelegenheiten
Lp(a): a New Pathway to Target?
Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a)
Factors inducing cardiovascular events in patients treated by lipoprotein apheresis
The German Lipoprotein Apheresis Registry (GLAR) – almost 5 years on
Lp(a) in der Routinelipiddiagnostik : Methoden und Interferenzen
Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels
Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification
Current Role of Lipoprotein Apheresis
Der Biomarker Lipoprotein(a) – Lp(a) in der Diagnostik der peripheren arteriellen Verschlusskrankheit
Der Biomarker Lipoprotein(a) – Lp(a) in der Diagnostik der peripheren arteriellen Verschlusskrankheit
[Abstract der Posterpräsentation] Bestimmung von Lipoprotein Lp(a): Vergleich zweier Enzymimmunoassays und eines Radioimmunoassays
LPA, Abt. LP 4 (Flak).- Personalangelegenheiten
Lp(a): a New Pathway to Target?
Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a)
Factors inducing cardiovascular events in patients treated by lipoprotein apheresis
The German Lipoprotein Apheresis Registry (GLAR) – almost 5 years on
Lp(a) in der Routinelipiddiagnostik : Methoden und Interferenzen
Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels
Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification
Current Role of Lipoprotein Apheresis
Der Biomarker Lipoprotein(a) – Lp(a) in der Diagnostik der peripheren arteriellen Verschlusskrankheit
Der Biomarker Lipoprotein(a) – Lp(a) in der Diagnostik der peripheren arteriellen Verschlusskrankheit
[Abstract der Posterpräsentation] Bestimmung von Lipoprotein Lp(a): Vergleich zweier Enzymimmunoassays und eines Radioimmunoassays
LPA, Abt. LP 4 (Flak).- Personalangelegenheiten
Lp(a): a New Pathway to Target?
Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a)
Factors inducing cardiovascular events in patients treated by lipoprotein apheresis
The German Lipoprotein Apheresis Registry (GLAR) – almost 5 years on